Boston, MA, US.
Market Access is a key commercial function that ensures transformative Vertex therapies are appropriately funded and ultimately make it into the hands of the patients around the world. The GVAS (Global Value & Access Strategy) team works cross-functionally and across regions to ensure the payer view is represented in commercial and development plans across the lifecycle. We are driven by a desire to deliver groundbreaking pricing & reimbursement solutions to allow our medicines to reach patients faster than ever before.
The Director, GVAS role will serve as Market Access Lead for our APOL-1 mediated kidney disease (AMKD) portfolio, with a focus on lead asset inaxaplin. Pipeline products for AMKD are in development to treat chronic kidney diseases in patients with APOL-1 genetic risk alleles. The individual will be responsible for leading the development of Global Market Access strategies, as well as co-lead for the Global Commercial Team. The role reports to Sr Director, Genetic Kidney Disease lead.
Key Responsibilities:
- Responsible for Global payer strategic planning to support value and access optimization for lead AMKD asset inaxaplin
- Lead development of Market Access strategies and core Global P&R deliverables operating within the cross-functional, cross-regional commercialization process
- Responsible for Global payer strategic planning to support value and access optimization; lead development of Global Payer Plan which integrates value evidence generation, strategic pricing, value communications, stakeholder engagement to support successful reimbursement and pricing
- Accountable for ensuring the market access and payer perspective is reflected in cross-functional strategies (e.g. commercial, product development, regulatory affairs)
- Ensure evidence prioritization required to capture value, support a differentiated target product profile (TPP), and ensure local pricing and access
- Support strategies with deep functional knowledge, in-depth market research, environmental data & analogs
- Inform financial forecasts
- Partner with Health Economics & Outcomes Research (HEOR), Real-World Evidence (RWE) and Global Marketing to ensure robust value proposition and integrated evidence plans are optimized to support global market access and reimbursement
- Lead development of Market Access strategies and core Global P&R deliverables operating within the cross-functional, cross-regional commercialization process
- Co-lead AMKD Global Commercial Team (with Global Marketing) and work cross-functionally and cross-regionally to develop optimal commercial strategies
- The Global Commercial Team facilitates development of a commercial strategy in order to maximize the lifetime value of the asset globally; is the primary hub for alignment and input into the Disease Strategy Team
- This role should ensure collaboration and drive alignment across Global Commercial Team and leadership to integrate market access strategy and ensure resourcing for commercial success
- Support P&MA capability building and thought leadership projects that advance knowledge of and readiness for the rapidly evolving Global payer environment
- Maintain industry awareness and proactively address changes in market trends, competition, product acceptance and new product releases and adjust Market Access plans accordingly
- Collaborate closely with HEOR, International P&R, Corporate Affairs, US Market Access, Countries, Marketing and Clinical Development counterparts to ensure value and access optimization
Education and Experience:
- BA/BS in field of study requiring quantitative analysis; advanced degree preferred
- 8+ years of direct biotechnology / pharmaceutical industry experience and/or payer experience
- Deep working knowledge of both US and ex-US healthcare systems required; experience in comparable Global role considered a plus
- Experience in leading cross-functional teams required
- Experience in specialty and/or rare disease access models preferred
- Demonstrated ability to think strategically and make sound pricing and market access recommendations
- Entrepreneurial, energetic, dynamic, enthusiastic, decisive, and self-motivated; possesses a sense of urgency with the ability and strong desire to “make things happen”
- Strong practical, quantitative and analytical skills combined with a sound understanding of how to successfully apply pricing & reimbursement / HEOR principles to support Vertex
- General experience in commercialization and drug development
- Exhibits outstanding written and oral communication skills, including the ability to effectively write and deliver presentations to professionals at all levels within Vertex
- Demonstrated relationship building at all levels of the organization and across geographies
- Recognized as a team player with excellent interpersonal skills who is flexible and reliable
- Displays sound ethics and a fit for Vertex’s core values
#LI-KM3
Flex Designation:Hybrid-Eligible Or On-Site Eligible
Flex Eligibility Status:
In this Hybrid-Eligible role, you can choose to be designated as:
1. Hybrid: work remotely up to two days per week; or select
2. On-Site: work five days per week on-site with ad hoc flexibility.
Note: The Flex status for this position is subject to Vertex’s Policy on Flex @ Vertex Program and may be changed at any time.
This job ad will be unpublished on 03/03/2025.
This job is posted by Vertex.
This link brings you to the website of Vertex.
Please mention that you found the role via EuropeanHealthEconomics.com. Thank you and good luck!
